Brain tissue collected after death from AD patients at various disease stages, including AD patients who displayed cognitive loss, control subjects without AD, APP, APP xPS1, and 3xTg-AD mice, and control subjects, were used in studies to ascertain the connection between P-tau and Aβ. Here, MAPT is linked to Alzheimer disease.